Show simple item record

dc.contributor.advisorSheppard, Kate G.en
dc.contributor.authorFerrell, Melissa Leann
dc.creatorFerrell, Melissa Leannen
dc.date.accessioned2015-08-11T22:03:57Zen
dc.date.available2015-08-11T22:03:57Zen
dc.date.issued2015en
dc.identifier.urihttp://hdl.handle.net/10150/565918en
dc.description.abstractOne of the most common reasons people seek primary care and emergency care is to reduce the symptoms of allergies, such as hay fever. To meet this high demand, several recent FDA-approved methods for treating seasonal and perennial allergies have been developed, including sublingual immunotherapy tablets. Furthermore, no longer must a patient endure allergy shots; this can now be delivered sublingually. Although this method has been shown to have high safety and efficacy, very few clinicians actually utilize this form of therapy. The purpose of this paper is describe the use of sublingual immunotherapy among Nurse Practitioners (NPs) and discuss barriers that may prevent its use. Nurse Practitioners working in primary care settings were surveyed regarding their use of sublingual immunotherapy. Although many nurse practitioners treat patients with allergic disease, not one participant reported using sublingual immunotherapy. This discussion outlines some of the reasons NPs are not currently utilizing this method of allergy treatment and the findings are compared with the extant literature. This paper culminates in an evidence-based algorithm to outline best practices for utilizing sublingual immunotherapy to reduce allergy symptoms.
dc.language.isoen_USen
dc.publisherThe University of Arizona.en
dc.rightsCopyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.en
dc.subjectallergyen
dc.subjectallergy dropsen
dc.subjectasthmaen
dc.subjectnurse practitoneren
dc.subjectsublingual immunotherapyen
dc.subjectNursingen
dc.subjectallergic rhinitisen
dc.titleSublingual Immunotherapyen_US
dc.typetexten
dc.typeElectronic Dissertationen
dc.contributor.chairSheppard, Kate G.en
thesis.degree.grantorUniversity of Arizonaen
thesis.degree.leveldoctoralen
dc.contributor.committeememberSheppard, Kate G.en
dc.contributor.committeememberPiotrowski, Kathleenen
dc.contributor.committeememberPacheco, Christy L.en
thesis.degree.disciplineGraduate Collegeen
thesis.degree.disciplineNursingen
thesis.degree.nameD.N.P.en
refterms.dateFOA2018-09-10T00:34:34Z
html.description.abstractOne of the most common reasons people seek primary care and emergency care is to reduce the symptoms of allergies, such as hay fever. To meet this high demand, several recent FDA-approved methods for treating seasonal and perennial allergies have been developed, including sublingual immunotherapy tablets. Furthermore, no longer must a patient endure allergy shots; this can now be delivered sublingually. Although this method has been shown to have high safety and efficacy, very few clinicians actually utilize this form of therapy. The purpose of this paper is describe the use of sublingual immunotherapy among Nurse Practitioners (NPs) and discuss barriers that may prevent its use. Nurse Practitioners working in primary care settings were surveyed regarding their use of sublingual immunotherapy. Although many nurse practitioners treat patients with allergic disease, not one participant reported using sublingual immunotherapy. This discussion outlines some of the reasons NPs are not currently utilizing this method of allergy treatment and the findings are compared with the extant literature. This paper culminates in an evidence-based algorithm to outline best practices for utilizing sublingual immunotherapy to reduce allergy symptoms.


Files in this item

Thumbnail
Name:
azu_etd_14035_sip1_m.pdf
Size:
1.207Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record